Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Fasenra


To avoid

Contraindicated
Fasenra :
Type Medicine Authorised
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory AstraZeneca
Responsible Party AstraZeneca AB
Origin Sweden
Manufacturer Catalent Indiana LLC
Origin U.S.A.
ATC R03DX10

Your comment will appear shortly after approval

Fasenra :

Revision Date : 27/08/2019


Effect Frequency
Anaphylactic reactions Not known
Fever Common
Hypersensitivity reactions Common
Injection site reaction Very Common
Pharyngitis Common
Postdural puncture headache Common

Different Units By MoH Code

Revision Date : 09/04/2020

Revision Date : 09/04/2020

Fasenra  MoH 10762 :
Form Solution for injection
Packaging Pre-filled pen
Package Size 1x1ml
Strength 30mg
Storage Condition 2-8°C Protect from light. Do not freeze
Public Price 214213273,13 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 128820/1
Submission date 2020
Registration Year 08/04/2022


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x1ml
● Public Price: 214213273.13 LBP ( 214,213,273.13 LBP )
● Pack size unit used: 1
● Cost/Unit: 214213273,13 LBP ( 214,213,273.00 LBP )
● Pricing Date: 10/11/2025

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Severe eosinophilic asthma : (Adults)
● Cost/Unit: 214213273,13 LBP ( 214,213,273.00 LBP )
● Cost/Day: 214213273,13 LBP ( 214,213,273.00 LBP )
● Cost/Month: 214213273,13 LBP ( 214,213,273.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info